— Know what they know.
Not Investment Advice

Financial News

Sentiment 36.3 5256 articles 2740 bullish 1142 bearish Full Index →
📰

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026

Conference call today, March 23, 2026, at 4:30 PM ET Conference call today, March 23, 2026, at 4:30 PM ET
📰

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates ABTECT Phase 3 Data Safety Monitoring Board (DSMB) meeting on March...
📰

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
What's Going On With Eli Lilly On Monday?

What's Going On With Eli Lilly On Monday?

More than 80 global executives gathered in Beijing for the China Development Forum, signaling renewed corporate interest in the Chinese market...
What's Going On With Eli Lilly On Monday?

What's Going On With Eli Lilly On Monday?

More than 80 global executives gathered in Beijing for the China Development Forum, signaling renewed corporate interest in the Chinese market...
The Upside Debate: UnitedHealth's Consistency vs. Centene's

The Upside Debate: UnitedHealth's Consistency vs. Centene's Comeback

UNH's steady execution and diversified model face off against CNC's turnaround bid as cost pressures and policy shifts reshape upside potential.
The Upside Debate: UnitedHealth's Consistency vs. Centene's

The Upside Debate: UnitedHealth's Consistency vs. Centene's Comeback

UNH's steady execution and diversified model face off against CNC's turnaround bid as cost pressures and policy shifts reshape upside potential.
📰

PACS or MEDP: Which Is the Better Value Stock Right Now?

PACS vs. MEDP: Which Stock Is the Better Value Option?
📰

CSLLY vs. ARGX: Which Stock Is the Better Value Option?

CSLLY vs. ARGX: Which Stock Is the Better Value Option?
📰

CSLLY vs. ARGX: Which Stock Is the Better Value Option?

CSLLY vs. ARGX: Which Stock Is the Better Value Option?
📰

NVST or SYK: Which Is the Better Value Stock Right Now?

NVST vs. SYK: Which Stock Is the Better Value Option?
📰

NVST or SYK: Which Is the Better Value Stock Right Now?

NVST vs. SYK: Which Stock Is the Better Value Option?
Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH

Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock?

CAH sees GLP-1 drugs boost revenue growth, but margins lag as strong demand lifts volumes without significantly improving profitability.
Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH

Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock?

CAH sees GLP-1 drugs boost revenue growth, but margins lag as strong demand lifts volumes without significantly improving profitability.
Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH

Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock?

CAH sees GLP-1 drugs boost revenue growth, but margins lag as strong demand lifts volumes without significantly improving profitability.
Hims & Hers Expands Integrated Digital Healthcare Ecosystem

Hims & Hers Expands Integrated Digital Healthcare Ecosystem

HIMS builds a seamless digital healthcare ecosystem, expanding into diagnostics, global markets and specialty care to reshape access and delivery.
Hims & Hers Expands Integrated Digital Healthcare Ecosystem

Hims & Hers Expands Integrated Digital Healthcare Ecosystem

HIMS builds a seamless digital healthcare ecosystem, expanding into diagnostics, global markets and specialty care to reshape access and delivery.
Hims & Hers Expands Integrated Digital Healthcare Ecosystem

Hims & Hers Expands Integrated Digital Healthcare Ecosystem

HIMS builds a seamless digital healthcare ecosystem, expanding into diagnostics, global markets and specialty care to reshape access and delivery.
NVO vs. GPCR: Which Obesity Stock is the Better Buy Right No

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?

Novo Nordisk faces slowing growth and rising competition, while Structure Therapeutics shows strong obesity study results, highlighting a clash of...
📰
📰
📰

Are Medical Stocks Lagging American Well (AMWL) This Year?

Here is how American Well Corporation (AMWL) and Annexon, Inc. (ANNX) have performed compared to their sector so far this year.
📰

Are Medical Stocks Lagging American Well (AMWL) This Year?

Here is how American Well Corporation (AMWL) and Annexon, Inc. (ANNX) have performed compared to their sector so far this year.
📰

5 High-Yield Stocks to Shield Your Portfolio From the Storm

With the S&P 500 breaking below its 200-day SMA, high-yield dividend stocks are increasingly worth considering as a source of income and...
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Atten

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the...
📰

Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 23, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG ((SIX: MOLN, NASDAQ:MOLN), a...
📰

Supporting Manufacturers Across Pennsylvania, Ohio, and Michigan with Industrial Air Solutions

As manufacturing continues to grow across the Mid-Atlantic and Midwest, companies are increasingly relying on trusted regional partners to keep...
📰

China SXT Pharmaceuticals, Inc. Announces Share Re-classification

TAIZHOU, China, March 23, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”),  a specialty...
Cyberonix and Korea University College of Informatics Sign M

Cyberonix and Korea University College of Informatics Sign MOU to Advance AI Research and Industry Collaboration

LOS ANGELES, March 23, 2026 /PRNewswire/ -- Cyberonix Experts, LLC ("Cyberonix"), a faculty-led software expert witness and technical advisory firm...
Intelligenome Announces R&D Subaward Agreement with Corn

Intelligenome Announces R&D Subaward Agreement with Cornell University to Advance Rapid Point-of-Care Tuberculosis Diagnosis

HOUSTON, March 23, 2026 /PRNewswire/ -- Intelligenome, a global leader in CRISPR-based in vitro diagnostic (IVD) technology, is pleased to announce...
📰

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
Ascensus Launches Two New Pooled Employer Plans (PEPs) with

Ascensus Launches Two New Pooled Employer Plans (PEPs) with OneDigital

New 401(k) and 403(b) PEPs Expand Retirement Access DRESHER, Pa., March 23, 2026 /PRNewswire/ -- Ascensus, the leading independent technology and...
📰

MaxCyte appoints Parmeet Ahuja as CFO

📰
📰

How FDA Review of Sarepta’s ESSENCE Data At Sarepta Therapeutics (SRPT) Has Changed Its Investment Story

Sarepta Therapeutics recently updated investors that the FDA has agreed it can file supplemental applications by the end of April to seek conversion...
📰

MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer

ROCKVILLE, Md., March 23, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (NASDAQ:MXCT), a leading cell-engineering focused company providing enabling...
FusionEdge Solutions to Modernize and Support U.S. Food and

FusionEdge Solutions to Modernize and Support U.S. Food and Drug Administration's (FDA) Unified Registration and Listing System (FURLS)

STERLING, Va., March 23, 2026 /PRNewswire/ -- FusionEdge Solutions, a joint venture between REI Systems and TechSur Solutions, has been awarded a $16...
📰

NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session

NAARDEN, The Netherlands and MIAMI, March 23, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a late-stage, clinical...
📰

Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors

-- Ms. Jarrett brings nearly three decades of executive leadership in biotech, tech and finance -- -- Biotech leaders Dr. Cameron Turtle and Mike...
📰

NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session

NAARDEN, The Netherlands and MIAMI, March 23, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a late-stage, clinical...
📰

Levi & Korsinsky, LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of BioXcel Therapeutics, Inc.

HARTFORD, Conn., March 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that the United States District Court for the District of...
📰

On National Viagra Day, Women Finally Claim Their Turn:

DARE to PLAY™ Sildenafil Cream Is Rewriting the Story of Sexual Health — For Her DARE to PLAY™ Sildenafil Cream Is Rewriting the Story of Sexual...
« Prev 1 8 9 10 11 12 16 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms